Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

@article{Riepe2007RecentAI,
  title={Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency},
  author={Felix G{\"u}nther Riepe and Wolfgang G. Sippell},
  journal={Reviews in Endocrine and Metabolic Disorders},
  year={2007},
  volume={8},
  pages={349-363}
}
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal-recessive disease causing cortisol deficiency, aldosterone deficiency and hyperandrogenism. Diagnosis of 21-OHD is confirmed by steroid analysis in newborn screening or later on. Standard medical treatment consists of oral glucocorticoid and mineralocorticoid administration in order to suppress adrenal androgens and to compensate for adrenal steroid deficiencies. However, available treatment is far… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 144 references

Improved Glucocorticoid Replacement Therapy by a Novel Oral Hydrocortisone Modified-Release Tablet

  • G Johannsson, R Bergthorsdottir, A Nilsson, H Lennernas, T Hedner, S. Skrtic
  • 89th Annual Meeting of the Endocrine Society
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…